Dosing & Uses
AdultPediatric
Dosage Forms & Strengths
ophthalmic solution
- 1%
Discontinued in U.S.
Product was used for postoperative Inflammation and anterior uveitis
Safety and efficacy not established
Next:
Adverse Effects
Frequency Not Defined
Glaucoma
Cataract
Potentiate super infection
Slow wound healing
Previous
Next:
Warnings
Contraindications
Hypersensitivity to any component of the formulation
Herpes simplex keratitis, herpes simplex keratitis dendritic, ocular fungal disease, ocular tuberculosis, ocular viral disease
Previous
Next:
Pregnancy & Lactation
Pregnancy Category: C
Lactation: ophthalmic corticosteroids have not been reported to cause problems in nursing babies
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Previous
Next:
Pharmacology
Absorption: following topical instillation of corticosteroids into the conjunctival sac, is absorbed into the aqueous humor, & systemic absorption occurs
Mechanism of Action
Synthetic nonfluorinated corticosteroid
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
